Your browser doesn't support javascript.
loading
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder, Simon Peter; Peer, Andreas; Weismann, Christian; Meissnitzer, Matthias; Rinnerthaler, Gabriel; Webhofer, Johanna; Westphal, Theresa; Riedmann, Marina; Meissnitzer, Thomas; Egger, Heike; Klaassen Federspiel, Frederike; Reitsamer, Roland; Hauser-Kronberger, Cornelia; Stering, Katharina; Hergan, Klaus; Mlineritsch, Brigitte; Greil, Richard.
Affiliation
  • Gampenrieder SP; Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.
  • Peer A; Cancer Cluster Salzburg, Salzburg, Austria.
  • Weismann C; Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.
  • Meissnitzer M; Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Rinnerthaler G; Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Webhofer J; Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.
  • Westphal T; Cancer Cluster Salzburg, Salzburg, Austria.
  • Riedmann M; Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.
  • Meissnitzer T; Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.
  • Egger H; Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, Innsbruck, Austria.
  • Klaassen Federspiel F; Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Reitsamer R; Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Hauser-Kronberger C; Department of Special Gynecology and Breast Center, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Stering K; Department of Special Gynecology and Breast Center, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Hergan K; Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Mlineritsch B; Department of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Greil R; Department of Radiology, Paracelsus Medical University Salzburg, Salzburg, Austria.
Breast Cancer Res ; 21(1): 19, 2019 01 31.
Article in En | MEDLINE | ID: mdl-30704493

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Magnetic Resonance Imaging / Antineoplastic Combined Chemotherapy Protocols / Neoplasm Recurrence, Local Type of study: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Austria Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Magnetic Resonance Imaging / Antineoplastic Combined Chemotherapy Protocols / Neoplasm Recurrence, Local Type of study: Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Austria Country of publication: Reino Unido